Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on Phare Bio — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Phare Bio Awarded Up To $27 Million from ARPA-H for AI-Powered Drug Discovery and Developing New Antibiotics
Sep 26, 2024•over 1 year ago
Contract Type
agreement
Description
Phare Bio, along with MIT's Collins Lab and Harvard's Wyss Institute, has been awarded up to $27 million in funding from ARPA-H to enhance their generative AI discovery platform and produce novel classes of antibiotics.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months